Kirk A Rockett1,2, Thomas N Williams3,4, Carolyne M Ndila3, Vysaul Nyirongo5, Alexander W Macharia3, Anna E Jeffreys1, Kate Rowlands1, Christina Hubbart1, George B J Busby1,6, Gavin Band1,2, Rosalind M Harding7. 1. Wellcome Centre for Human Genetics, University of Oxford, Oxford, Oxfordshire, OX3 7BN, UK. 2. Parasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK. 3. Department of Epidemiology and Demography, KEMRI-Wellcome Trust Research Programme, Kilifi, PO BOX 230-80108, Kenya. 4. Department of Infectious Diseases, Imperial College Faculty of Medicine, London, W2 1NY, UK. 5. United Nation Statistics Division, United Nations, New York, New York, 10017, USA. 6. Centre for Genomics and Global Health, Big Data Institute, University of Oxford, Oxford, Oxfordshire, OX3 7LF, UK. 7. Departments of Zoology and Statistics, University of Oxford, Oxford, Oxfordshire, OX1 3SZ, UK.
Abstract
Background: The -α 3.7I-thalassaemia deletion is very common throughout Africa because it protects against malaria. When undertaking studies to investigate human genetic adaptations to malaria or other diseases, it is important to account for any confounding effects of α-thalassaemia to rule out spurious associations. Methods: In this study, we have used direct α-thalassaemia genotyping to understand why GWAS data from a large malaria association study in Kilifi Kenya did not identify the α-thalassaemia signal. We then explored the potential use of a number of new approaches to using GWAS data for imputing α-thalassaemia as an alternative to direct genotyping by PCR. Results: We found very low linkage-disequilibrium of the directly typed data with the GWAS SNP markers around α-thalassaemia and across the haemoglobin-alpha ( HBA) gene region, which along with a complex haplotype structure, could explain the lack of an association signal from the GWAS SNP data. Some indirect typing methods gave results that were in broad agreement with those derived from direct genotyping and could identify an association signal, but none were sufficiently accurate to allow correct interpretation compared with direct typing, leading to confusing or erroneous results. Conclusions: We conclude that going forwards, direct typing methods such as PCR will still be required to account for α-thalassaemia in GWAS studies. Copyright:
Background: The -α 3.7I-thalassaemia deletion is very common throughout Africa because it protects against malaria. When undertaking studies to investigate human genetic adaptations to malaria or other diseases, it is important to account for any confounding effects of α-thalassaemia to rule out spurious associations. Methods: In this study, we have used direct α-thalassaemia genotyping to understand why GWAS data from a large malaria association study in Kilifi Kenya did not identify the α-thalassaemia signal. We then explored the potential use of a number of new approaches to using GWAS data for imputing α-thalassaemia as an alternative to direct genotyping by PCR. Results: We found very low linkage-disequilibrium of the directly typed data with the GWAS SNP markers around α-thalassaemia and across the haemoglobin-alpha ( HBA) gene region, which along with a complex haplotype structure, could explain the lack of an association signal from the GWAS SNP data. Some indirect typing methods gave results that were in broad agreement with those derived from direct genotyping and could identify an association signal, but none were sufficiently accurate to allow correct interpretation compared with direct typing, leading to confusing or erroneous results. Conclusions: We conclude that going forwards, direct typing methods such as PCR will still be required to account for α-thalassaemia in GWAS studies. Copyright:
Authors: Thomas N Williams; Sammy Wambua; Sophie Uyoga; Alex Macharia; Jedidah K Mwacharo; Charles R J C Newton; Kathryn Maitland Journal: Blood Date: 2005-03-15 Impact factor: 22.113
Authors: Thomas N Williams; Tabitha W Mwangi; Sammy Wambua; Timothy E A Peto; David J Weatherall; Sunetra Gupta; Mario Recker; Bridget S Penman; Sophie Uyoga; Alex Macharia; Jedidah K Mwacharo; Robert W Snow; Kevin Marsh Journal: Nat Genet Date: 2005-10-16 Impact factor: 38.330
Authors: Sammy Wambua; Tabitha W Mwangi; Moses Kortok; Sophie M Uyoga; Alex W Macharia; Jedidah K Mwacharo; David J Weatherall; Robert W Snow; Kevin Marsh; Thomas N Williams Journal: PLoS Med Date: 2006-04-18 Impact factor: 11.069
Authors: D Herbert Opi; Lucy B Ochola; Metrine Tendwa; Bethsheba R Siddondo; Harold Ocholla; Harry Fanjo; Ashfaq Ghumra; David J P Ferguson; J Alexandra Rowe; Thomas N Williams Journal: EBioMedicine Date: 2014-11-01 Impact factor: 8.143
Authors: Gavin Band; Quang Si Le; Luke Jostins; Matti Pirinen; Katja Kivinen; Muminatou Jallow; Fatoumatta Sisay-Joof; Kalifa Bojang; Margaret Pinder; Giorgio Sirugo; David J Conway; Vysaul Nyirongo; David Kachala; Malcolm Molyneux; Terrie Taylor; Carolyne Ndila; Norbert Peshu; Kevin Marsh; Thomas N Williams; Daniel Alcock; Robert Andrews; Sarah Edkins; Emma Gray; Christina Hubbart; Anna Jeffreys; Kate Rowlands; Kathrin Schuldt; Taane G Clark; Kerrin S Small; Yik Ying Teo; Dominic P Kwiatkowski; Kirk A Rockett; Jeffrey C Barrett; Chris C A Spencer Journal: PLoS Genet Date: 2013-05-23 Impact factor: 5.917
Authors: S Uyoga; J A Watson; P Wanjiku; J C Rop; J Makale; A W Macharia; S N Kariuki; G M Nyutu; M Shebe; M Mosobo; N Mturi; K A Rockett; C J Woodrow; A M Dondorp; K Maitland; N J White; T N Williams Journal: Nat Commun Date: 2022-06-08 Impact factor: 17.694
Authors: James A Watson; Carolyne M Ndila; Thomas N Williams; Chris C Holmes; Nicholas J White; Sophie Uyoga; Alexander Macharia; Gideon Nyutu; Shebe Mohammed; Caroline Ngetsa; Neema Mturi; Norbert Peshu; Benjamin Tsofa; Kirk Rockett; Stije Leopold; Hugh Kingston; Elizabeth C George; Kathryn Maitland; Nicholas Pj Day; Arjen M Dondorp; Philip Bejon Journal: Elife Date: 2021-07-06 Impact factor: 8.140